Clinical Trial Details
EORTC-20991
Back to Clinical Trials Database
Diffuse large B cell and peripheral T cell non-Hodgkin's lymphomas in the elderly. Influence of prolonged oral etoposide added to CHOP combination chemotherapy in patients with good physiological status. An EORTC phase II-III trial including geriatric assessment and quality of life.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 19-Mar-2003 Date Step1 close: 13-Aug-2004 |
Data management at EORTC | Yes |
Design |
Phase 2-3 Randomized open label |
Targeted Sample size | EORTC Groups: 126 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00060385 |
NCT number | NCT00060385 |